April 27, 2026
How US Drug Pricing Reforms Are Reshaping Innovation
US drug pricing reforms have fundamentally altered the economics of biopharmaceutical innovation. Multiple…
April 20, 2026
Reforming the Accelerated Approval Pathway
The accelerated approval pathway has transformed access to treatments for serious conditions since…
April 13, 2026
Lenacapavir PrEP Marks New Chapter in South African HIV Prevention
The recent arrival of lenacapavir PrEP in South Africa signals a notable advance…
April 6, 2026
NICE Thresholds Drive Better Medicine Access
NICE thresholds now sit at £25,000 to £35,000 per quality-adjusted life year following…
March 30, 2026
Portugal Biotech Gains Global Momentum
Portugal biotech has stepped firmly onto the European stage. The recent BIO-Europe Spring…
March 23, 2026
Companies Strengthen Antimicrobial Access Plans
The shrinking pipeline of new antibiotics makes antimicrobial access a pressing concern for…
